BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ahmed A. A critical evaluation of vancomycin for treatment of bacterial meningitis. Pediatr Infect Dis J 1997;16:895-903. [PMID: 9306486 DOI: 10.1097/00006454-199709000-00014] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Goff DA, Sierawski SJ. Clinical Experience of Quinupristin-Dalfopristin for the Treatment of Antimicrobial-Resistant Gram-Positive Infections. Pharmacotherapy 2002;22:748-58. [DOI: 10.1592/phco.22.9.748.34068] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
2 Cottagnoud P, Acosta F, Cottagnoud M, Pfister M, Täuber MG. Efficacies of BMS 284756 against penicillin-sensitive, penicillin-resistant, and quinolone-resistant pneumococci in experimental meningitis. Antimicrob Agents Chemother 2002;46:184-7. [PMID: 11751131 DOI: 10.1128/AAC.46.1.184-187.2002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
3 Tunkel AR, Scheld WM. Treatment of bacterial meningitis. Curr Infect Dis Rep 2002;4:7-16. [DOI: 10.1007/s11908-002-0062-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
4 Rodoni D, Hänni F, Gerber CM, Cottagnoud M, Neftel K, Täuber MG, Cottagnoud P. Trovafloxacin in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model. Antimicrob Agents Chemother 1999;43:963-5. [PMID: 10103211 DOI: 10.1128/AAC.43.4.963] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
5 Uhl P, Pantze S, Storck P, Parmentier J, Witzigmann D, Hofhaus G, Huwyler J, Mier W, Fricker G. Oral delivery of vancomycin by tetraether lipid liposomes. European Journal of Pharmaceutical Sciences 2017;108:111-8. [DOI: 10.1016/j.ejps.2017.07.013] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 7.4] [Reference Citation Analysis]
6 Cottagnoud P, Acosta F, Cottagnoud M, Täuber MG. Gemifloxacin is efficacious against penicillin-resistant and quinolone-resistant pneumococci in experimental meningitis. Antimicrob Agents Chemother 2002;46:1607-9. [PMID: 11959614 DOI: 10.1128/AAC.46.5.1607-1609.2002] [Cited by in Crossref: 16] [Article Influence: 0.8] [Reference Citation Analysis]
7 Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, Whitley RJ. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004;39:1267-1284. [PMID: 15494903 DOI: 10.1086/425368] [Cited by in Crossref: 1286] [Cited by in F6Publishing: 921] [Article Influence: 71.4] [Reference Citation Analysis]
8 Willems J, Hermans E, Schelstraete P, Depuydt P, De Cock P. Optimizing the Use of Antibiotic Agents in the Pediatric Intensive Care Unit: A Narrative Review. Paediatr Drugs 2021;23:39-53. [PMID: 33174101 DOI: 10.1007/s40272-020-00426-y] [Reference Citation Analysis]
9 Levine DP. Vancomycin: a history. Clin Infect Dis. 2006;42 Suppl 1:S5-12. [PMID: 16323120 DOI: 10.1086/491709] [Cited by in Crossref: 450] [Cited by in F6Publishing: 381] [Article Influence: 28.1] [Reference Citation Analysis]
10 Krueger WA, Kottler B, Will BE, Heininger A, Guggenberger H, Unertl KE. Treatment of meningitis due to methicillin-resistant Staphylococcus epidermidis with linezolid. J Clin Microbiol 2004;42:929-32. [PMID: 14766894 DOI: 10.1128/JCM.42.2.929-932.2004] [Cited by in Crossref: 41] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
11 Cottagnoud P, Gerber CM, Cottagnoud M, Täuber MG. Gentamicin increases the efficacy of vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model. Antimicrob Agents Chemother 2002;46:188-90. [PMID: 11751132 DOI: 10.1128/AAC.46.1.188-190.2002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
12 Wilhelm MP, Estes L. Vancomycin. Mayo Clinic Proceedings 1999;74:928-35. [DOI: 10.4065/74.9.928] [Cited by in Crossref: 58] [Cited by in F6Publishing: 50] [Article Influence: 2.5] [Reference Citation Analysis]
13 Hameed N, Tunkel AR. Treatment of Drug-resistant Pneumococcal Meningitis. Curr Infect Dis Rep. 2010;12:274-281. [PMID: 21308542 DOI: 10.1007/s11908-010-0110-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
14 Gerber P, Stucki A, Acosta F, Cottagnoud M, Cottagnoud P. Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis. J Antimicrob Chemother 2006;57:720-3. [PMID: 16459345 DOI: 10.1093/jac/dkl007] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 3.7] [Reference Citation Analysis]
15 Cottagnoud P, Acosta F, Cottagnoud M, Neftel K, Täuber MG. Synergy between trovafloxacin and ceftriaxone against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro. Antimicrob Agents Chemother 2000;44:2179-81. [PMID: 10898696 DOI: 10.1128/AAC.44.8.2179-2181.2000] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
16 Rocha P, Baleeiro C, Tunkel AR. Impact of Antimicrobial Resistance on the Treatment of Invasive Pneumococcal Infections. Curr Infect Dis Rep 2000;2:399-408. [PMID: 11095884 DOI: 10.1007/s11908-000-0066-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
17 Rodrigues MM, Patrocínio SJ, Rodrigues MG. Staphylococcus aureus meningitis in children: a review of 30 community-acquired cases. Arq Neuro-Psiquiatr 2000;58:843-51. [DOI: 10.1590/s0004-282x2000000500009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]